Literature DB >> 20674736

Lower respiratory tract infection in cynomolgus macaques (Macaca fascicularis) infected with group A Streptococcus.

Randall J Olsen1, Madiha Ashraf, Vedia E Gonulal, Ara A Ayeras, Concepcion Cantu, Patrick R Shea, Ronan K Carroll, Tammy Humbird, Jamieson L Greaver, Jody L Swain, Ellen Chang, Willie Ragasa, Leslie Jenkins, Kevin P Lally, Terry Blasdel, Philip Cagle, James M Musser.   

Abstract

Group A Streptococcus (GAS), a human-specific pathogen, is best known for causing pharyngitis ("strep-throat") and necrotizing fasciitis ("flesh-eating disease"). However, the organism is also an uncommon but important cause of community-acquired bronchopneumonia, an infection with an exceptionally high mortality rate. Inasmuch as little is known about the molecular pathogenesis of GAS lower respiratory tract infection, we sought to develop a relevant human infection model. Nine cynomolgus macaques were infected by intra-bronchial instillation of either sterile saline or GAS (10(5) or 10(7) CFU). Animals were continuously monitored and sacrificed at five days post-inoculation. Serial bronchial alveolar lavage specimens and tissues collected at necropsy were used for histologic and immunohistochemical examination, quantitative microbial culture, lung and blood biomarker analysis, and in vivo GAS gene expression studies. The lower respiratory tract disease observed in cynomolgus macaques mimicked the clinical and pathological features of severe GAS bronchopneumonia in humans. This new monkey model will be useful for testing hypotheses bearing on the molecular pathogenesis of GAS in the lower respiratory tract.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20674736     DOI: 10.1016/j.micpath.2010.06.012

Source DB:  PubMed          Journal:  Microb Pathog        ISSN: 0882-4010            Impact factor:   3.738


  10 in total

Review 1.  The Unexpected Impact of Vaccines on Secondary Bacterial Infections Following Influenza.

Authors:  Amber M Smith; Victor C Huber
Journal:  Viral Immunol       Date:  2017-11-17       Impact factor: 2.257

2.  Inactivated and live, attenuated influenza vaccines protect mice against influenza: Streptococcus pyogenes super-infections.

Authors:  Michael S Chaussee; Heather R Sandbulte; Margaret J Schuneman; Frank P Depaula; Leslie A Addengast; Evelyn H Schlenker; Victor C Huber
Journal:  Vaccine       Date:  2011-04-08       Impact factor: 3.641

3.  Virulence of serotype M3 Group A Streptococcus strains in wax worms (Galleria mellonella larvae).

Authors:  Randall J Olsen; M Ebru Watkins; Concepcion C Cantu; Stephen B Beres; James M Musser
Journal:  Virulence       Date:  2011-03-01       Impact factor: 5.882

4.  Tissue Tropism in Streptococcal Infection: Wild-Type M1T1 Group A Streptococcus Is Efficiently Cleared by Neutrophils Using an NADPH Oxidase-Dependent Mechanism in the Lung but Not in the Skin.

Authors:  Benfang Lei; Dylan Minor; Wenchao Feng; Maria Jerome; Mark T Quinn; Mark A Jutila; Mengyao Liu
Journal:  Infect Immun       Date:  2019-09-19       Impact factor: 3.441

5.  Vaccination against the M protein of Streptococcus pyogenes prevents death after influenza virus: S. pyogenes super-infection.

Authors:  Joshua M Klonoski; Heather R Hurtig; Brian A Juber; Margaret J Schuneman; Thomas E Bickett; Joshua M Svendsen; Brandon Burum; Thomas A Penfound; Grigoriy Sereda; James B Dale; Michael S Chaussee; Victor C Huber
Journal:  Vaccine       Date:  2014-07-29       Impact factor: 3.641

6.  Long-term deep sedation using Zoletil and haloperidol for the treatment of streptococcal pneumonia in an orangutan (Pongo pygmaeus).

Authors:  Paolo Martelli; Serena Oh
Journal:  J Vet Med Sci       Date:  2021-03-24       Impact factor: 1.267

7.  Deprenyl reduces inflammation during acute SIV infection.

Authors:  K M Emanuel; K Runner; Z D Brodnik; B M Morsey; B G Lamberty; H S Johnson; A Acharya; S N Byrareddy; R A España; H S Fox; P J Gaskill
Journal:  iScience       Date:  2022-04-06

Review 8.  Port d'Entrée for Respiratory Infections - Does the Influenza A Virus Pave the Way for Bacteria?

Authors:  Nikolai Siemens; Sonja Oehmcke-Hecht; Thomas C Mettenleiter; Bernd Kreikemeyer; Peter Valentin-Weigand; Sven Hammerschmidt
Journal:  Front Microbiol       Date:  2017-12-21       Impact factor: 5.640

9.  Immunotherapy targeting the Streptococcus pyogenes M protein or streptolysin O to treat or prevent influenza A superinfection.

Authors:  Andrea L Herrera; Christopher Van Hove; Mary Hanson; James B Dale; Rodney K Tweten; Victor C Huber; Diego Diel; Michael S Chaussee
Journal:  PLoS One       Date:  2020-06-23       Impact factor: 3.240

10.  A lung segmental model of chronic Pseudomonas infection in sheep.

Authors:  David Collie; John Govan; Steven Wright; Elisabeth Thornton; Peter Tennant; Sionagh Smith; Catherine Doherty; Gerry McLachlan
Journal:  PLoS One       Date:  2013-07-09       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.